Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: KLB003
MIFTS: 35

Klebsiella Pneumonia

Categories: Infectious diseases, Respiratory diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Klebsiella Pneumonia

About this section

MalaCards integrated aliases for Klebsiella Pneumonia:

Name: Klebsiella Pneumonia 12 55 15
Pneumonia Due to Klebsiella Pneumoniae 12
Klebsiella Infections 44

Classifications:

MalaCards categories:
Global: Infectious diseases
Anatomical: Respiratory diseases
See all MalaCards categories (disease lists)
ICD10: 33


External Ids:

Disease Ontology 12 DOID:13272
ICD10 33 J15.0 B96.1
ICD9CM 35 482.0
MeSH 44 D007710
Sources

Summaries for Klebsiella Pneumonia

About this section
Disease Ontology : 12 A bacterial pneumonia involving Klebsiella pneumoniae infection. Patients with Klebsiella pneumonia tend to cough up a characteristic sputum that is said to resemble \

MalaCards based summary : Klebsiella Pneumonia, also known as pneumonia due to klebsiella pneumoniae, is related to klebsiella infection and craniosynostosis 1. An important gene associated with Klebsiella Pneumonia is PLAT (Plasminogen Activator, Tissue Type), and among its related pathways/superpathways is Selenium Micronutrient Network. The drugs Colistin and Ceftriaxone have been mentioned in the context of this disorder. Affiliated tissues include lung, whole blood and prostate, and related phenotypes are Decreased shRNA abundance (Z-score < -2) and Decreased shRNA abundance (Z-score < -2)

Wikipedia : 76 Klebsiella pneumonia (KP) is a form of bacterial pneumonia associated with Klebsiella pneumoniae. It is... more...

Sources

Related Diseases for Klebsiella Pneumonia

About this section

Diseases related to Klebsiella Pneumonia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 133)
# Related Disease Score Top Affiliating Genes
1 klebsiella infection 12.7
2 craniosynostosis 1 11.2
3 keratoconus posticus circumscriptus 11.1
4 pneumonia 10.9
5 cerebrotendinous xanthomatosis 10.9
6 endophthalmitis 10.6
7 meningitis 10.5
8 acute cystitis 10.5
9 fasciitis 10.4
10 necrotizing fasciitis 10.4
11 spondyloarthropathy 1 10.4
12 spondylitis 10.4
13 arthritis 10.3
14 septic arthritis 10.3
15 lung abscess 10.3
16 osteomyelitis 10.3
17 epidural abscess 10.3
18 peritonitis 10.3
19 tetralogy of fallot 10.2
20 diabetes mellitus 10.2
21 mastitis 10.2
22 polyarteritis nodosa, childhood-onset 10.2
23 pyelonephritis 10.2
24 bacteriuria 10.2
25 splenic abscess 10.2
26 cellulitis 10.2
27 pyomyositis 10.2
28 endocarditis 10.1
29 orbital cellulitis 10.1
30 lemierre's syndrome 10.1
31 uveitis 10.1
32 mediastinitis 10.1
33 anterior uveitis 10.1
34 rheumatoid arthritis 10.1
35 neutropenia 10.1
36 hypopyon 10.1
37 meningoencephalitis 10.1
38 ecthyma 10.1
39 cystitis 10.1
40 gastroenteritis 10.1
41 myocarditis 10.1
42 cystic fibrosis 10.0
43 enterocolitis 10.0
44 spondylocarpotarsal synostosis syndrome 10.0
45 retinitis pigmentosa 4 10.0
46 burns 10.0
47 diabetic foot ulcers 10.0
48 gas gangrene 10.0
49 hematopoietic stem cell transplantation 10.0
50 leukemia 10.0

Graphical network of the top 20 diseases related to Klebsiella Pneumonia:



Diseases related to Klebsiella Pneumonia
Sources

Symptoms & Phenotypes for Klebsiella Pneumonia

About this section

GenomeRNAi Phenotypes related to Klebsiella Pneumonia according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased shRNA abundance (Z-score < -2) GR00366-A-10 9.36 GALE
2 Decreased shRNA abundance (Z-score < -2) GR00366-A-112 9.36 GALE
3 Decreased shRNA abundance (Z-score < -2) GR00366-A-148 9.36 MAT1A
4 Decreased shRNA abundance (Z-score < -2) GR00366-A-15 9.36 GALE MAT1A
5 Decreased shRNA abundance (Z-score < -2) GR00366-A-212 9.36 GALE
6 Decreased shRNA abundance (Z-score < -2) GR00366-A-33 9.36 GALE
7 Decreased shRNA abundance (Z-score < -2) GR00366-A-60 9.36 MAT1A
8 Decreased shRNA abundance (Z-score < -2) GR00366-A-72 9.36 GALE
9 Decreased shRNA abundance (Z-score < -2) GR00366-A-75 9.36 GALE
10 Decreased shRNA abundance (Z-score < -2) GR00366-A-87 9.36 MAT1A
Sources

Drugs & Therapeutics for Klebsiella Pneumonia

About this section

Drugs for Klebsiella Pneumonia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 99)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Colistin Approved Phase 4,Phase 3,Not Applicable 1264-72-8, 1066-17-7 5311054
2
Ceftriaxone Approved Phase 4 73384-59-5 5479530 5361919
3
Trimethoprim Approved, Vet_approved Phase 4,Phase 2 738-70-5 5578
4
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 85721-33-1 2764
5
leucovorin Approved Phase 4,Phase 2 58-05-9 6006 143
6
Ertapenem Approved, Investigational Phase 4,Phase 2,Phase 3 153832-46-3 150610
7
Sulfamethoxazole Approved Phase 4,Phase 2 723-46-6 5329
8
Piperacillin Approved Phase 4,Phase 3 66258-76-2 43672
9
Tazobactam Approved Phase 4,Phase 3 89786-04-9 123630
10
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
11
Cephalexin Approved, Investigational, Vet_approved Phase 4,Phase 2 15686-71-2 27447
12
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
13
Polyestradiol phosphate Approved Phase 4 28014-46-2
14
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
15
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
16 Estradiol valerate Approved, Investigational, Vet_approved Phase 4 979-32-8
17
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2 59-30-3 6037
18 Polymyxins Phase 4,Not Applicable
19 Gentamicins Phase 4,Not Applicable
20 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
21 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
22 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
23 Folic Acid Antagonists Phase 4,Phase 2
24 Antitubercular Agents Phase 4,Not Applicable
25 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
26 Vitamin B Complex Phase 4,Phase 2
27 Liver Extracts Phase 4
28 Renal Agents Phase 4,Phase 3,Phase 2
29 Cytochrome P-450 CYP1A2 Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
30 Antiprotozoal Agents Phase 4,Phase 3,Phase 2
31 Anti-Infective Agents, Urinary Phase 4,Phase 3,Phase 2
32 Trimethoprim, Sulfamethoxazole Drug Combination Phase 4,Phase 2
33 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
34 Folate Phase 4,Phase 2
35 Antimalarials Phase 4,Phase 2
36 Vitamin B9 Phase 4,Phase 2
37 Antiparasitic Agents Phase 4,Phase 3,Phase 2
38 Piperacillin, tazobactam drug combination Phase 4,Phase 3
39 beta-Lactamase Inhibitors Phase 4,Phase 3
40 Cephalosporins Phase 4,Phase 3
41 Bifidobacterium Phase 4
42 Contraceptives, Oral Phase 4
43 Fluoroquinolones Phase 4,Phase 2,Phase 3
44 Norgestimate, ethinyl estradiol drug combination Phase 4
45 Estradiol 17 beta-cypionate Phase 4
46 Contraceptive Agents Phase 4
47 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 2,Phase 3
48 Estradiol 3-benzoate Phase 4
49 Contraceptives, Oral, Combined Phase 4
50 Immunologic Factors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 70)
# Name Status NCT ID Phase Drugs
1 SDD for Eradicating CRKP Carriage Unknown status NCT01761487 Phase 4
2 Safety and Efficacy Study of High Dose Colistin Unknown status NCT02162966 Phase 4 High Dose Colistin;Standard Dose Colistin
3 Antibiotics for Klebsiella Liver Abscess Study Completed NCT01723150 Phase 4 Ciprofloxacin;Ceftriaxone;Trimethoprim/sulfamethoxazole;Ertapenem
4 Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs) Completed NCT00254696 Phase 4 Extended-Spectrum-Lactamases (ESBLs)
5 Tazocin Intervention Study Completed NCT00478855 Phase 4 Tazocin (Piperacillin/Tazobactem)
6 Study Evaluation Tazocin Intervention Completed NCT00488189 Phase 4 Tazocin (pipercillin/tazobactam)
7 Study of Antibiotic Utilization Measures and Control of ESBLs in China Completed NCT00488813 Phase 4 Third generation cephalosporins
8 NEOBIFI: Clinical Trial for the Prevention and/or Reduction of the Incidence of Colics in Infants Completed NCT03219931 Phase 4 Bifidobacterium breve BR03 and Bifidobacterium breve B632;Placebos
9 Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver Abscess Completed NCT00895089 Phase 4 Moxifloxacin (Avelox);ceftriaxone
10 Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Recruiting NCT02787863 Phase 4 Polioxidonium
11 Preventing Recurrent Urinary Tract Infections With α-D-mannose Recruiting NCT03497598 Phase 4 Mannose;Lactose
12 Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli Unknown status NCT00300560 Phase 3 Colistin
13 Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms Completed NCT00079989 Phase 3 tigecycline
14 Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitis Completed NCT03047954 Phase 3 Broncho-Vaxom;Placebo - Cap
15 Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP Completed NCT02166476 Phase 3 Meropenem-Vaborbactam;Piperacillin-Tazobactam;Levofloxacin;Saline
16 Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens Completed NCT01644643 Phase 3 Ceftazidime - Avibactam ( CAZ-AVI);Best Available Therapy;Metronidazole
17 Efficacy Of Bacterial Lysate In Asthmatic Children Completed NCT02541331 Phase 3
18 Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients Active, not recruiting NCT02729116 Phase 2, Phase 3 Sitafloxacin;Ertapenem
19 A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia Terminated NCT01110421 Phase 3 Cefepime placebo;Cefepime;Doripenem;Doripenem placebo;Amoxicillin/clavulanate potassium
20 Probiotics for Eradication of Carbapenem Resistant Klebsiella Pneumonia Unknown status NCT00722410 Phase 1, Phase 2 Polyethylene glycol
21 Pilot Study of the Effectiveness of Probiotics and Lactitol for the Decolonization of OXA-48 (Carbapenemase) Producing Klebsiella Pneumoniae Among Rectal Carriers Unknown status NCT02307383 Phase 2 Lactitol;Lactobacillus
22 Effect of Improved Oral Hygiene to Prevent Pneumonia in Hospitalized Patients Completed NCT00123123 Phase 2 chlorhexidine gluconate oral rinse (0.12%);placebo
23 Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis Completed NCT00930982 Phase 2 Ciprofloxacin (Cipro, BAYQ3939);Placebo
24 The SCOUT Study: "Short Course Therapy for Urinary Tract Infections in Children" Recruiting NCT01595529 Phase 2 Cefixime;Cephalexin;Trimethoprim/Sulfamethoxazole
25 Pentaglobin in CRE and PA Neutropenic Infections Not yet recruiting NCT03494959 Phase 2 Pentaglobin
26 A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects Completed NCT01262885 Phase 1 GSK2251052;Placebo
27 An Open-label, Randomized, Single Period, Parallel-Cohort Study To Evaluate Serum and Pulmonary Pharmacokinetics Following Single and Multiple Dose Administration of Intravenous GSK2251052 in Healthy Adult Subjects Completed NCT01267968 Phase 1 GSK2251052
28 Single and Multiple Dose Evaluation of QBKPN SSI In Healthy Volunteers Withdrawn NCT02897999 Phase 1
29 Microbiology and Clinical Outcome of Pneumonia Unknown status NCT00873522
30 Stool Transplantation to Reduce Antibiotic Resistance Transmission Unknown status NCT02461199
31 Effects of Probiotics on Improving the Gastrointestinal Function and Intestinal Bacterial Flora Unknown status NCT01428999 Not Applicable
32 Recurrent ESBL-producing Enterobacteriaceae Bacteremia: Risk Factor, Molecular Character and Susceptibility Change Unknown status NCT01392118
33 Assessing the Effect of Contact Isolation on Nosocomial Colonization With ESBL-EC in German Hematology/Oncology Wards Unknown status NCT02456818
34 The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy Completed NCT01612182
35 Community-Onset Bacteremia Due to ESBL Producing E.Coli or K.Pneumoniae in China: Prevalence, Risk Factors and Prognosis Completed NCT01961206
36 Double Carbapenem as Rescue Strategy for the Treatment of Carbapenemase-Producing Klebsiella Pneumoniae Infections Completed NCT03094494
37 Klebsiella Pneumoniae Necrotizing Fasciitis: Clinical and Microbiological Features Completed NCT01139112
38 A Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC). Completed NCT01266499 Not Applicable Colistin (Polymyxin E) 100mg x 4/d;both medications;will not receive PO treatment;PO Garamycin 80mg x 4/d
39 Efficacy of Intestinal Decontamination in Patients Colonized by Carbapenem-resistant Klebsiella Pneumoniae and Colistin Completed NCT02604849 Neomycin;Streptomycin;Gentamicins
40 Selective Digestive Decontamination in Carriers of Carbapenem-resistant Klebsiella Pneumoniae Completed NCT00753558 Not Applicable Arm #1 :Oral solution and buccal gel of gentamicin and polymyxin E. Arm #2: Placebo.
41 Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms Completed NCT01324726
42 Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care Completed NCT00167986 vancomycin-resistant enterococci and ESBL
43 Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units Completed NCT00167999 piperacillin-tazobactam
44 Inhibition Effects of Probiotics on Pathogens Associated With VAP Completed NCT02928042
45 A Post-Intervention Surveillance Study Regarding the Acquisition Rate of ESBL-KP, Ecoli Completed NCT00724919
46 Clinical and Microbiological Outcomes of Infections Due to Carbapenem-Resistant Gram-Negative Bacteria Completed NCT01041716
47 Qnr Genes in Enterobacteriaceae Completed NCT02834910
48 Heterologous Effects of BCG in Healthy UK Adults Completed NCT02380508 Not Applicable BCG SSI;BCG Sii
49 Detecting Infections Rapidly and Easily for Bacteremia Trial (DIREBT) Completed NCT01919762
50 Post-Authorization Study Evaluating Safety Of Tigecycline Completed NCT00827541 Tigecycline

Search NIH Clinical Center for Klebsiella Pneumonia

Cochrane evidence based reviews: klebsiella infections

Sources

Genetic Tests for Klebsiella Pneumonia

About this section
Sources

Anatomical Context for Klebsiella Pneumonia

About this section

MalaCards organs/tissues related to Klebsiella Pneumonia:

41
Lung, Whole Blood, Prostate, Myeloid, Brain, Spinal Cord, Thyroid
Sources

Publications for Klebsiella Pneumonia

About this section

Articles related to Klebsiella Pneumonia:

(show top 50) (show all 117)
# Title Authors Year
1
Tigecycline application in a 3-month-old infant with multiple drug resistant <i>Klebsiella pneumonia</i>: a case report. ( 29977345 )
2018
2
Spinal epidural abscess caused by a community acquired extended spectrum beta lactamase producing Klebsiella pneumonia. ( 30128293 )
2018
3
Risk factors for acquisition of OXA-48-producing Klebsiella pneumonia among contact patients: a multicentre study. ( 28882642 )
2018
4
The frequency of Klebsiella pneumonia encoding genes for CTX-M, TEM-1 and SHV-1 extended-spectrum beta lactamases enzymes isolated from urinary tract infection. ( 29433582 )
2018
5
Cefquinome-loaded microsphere formulations against Klebsiella pneumonia infection during experimental infections. ( 29649952 )
2018
6
Whole genome sequence revealed the fine transmission map of carbapenem-resistant Klebsiella pneumonia isolates within a nosocomial outbreak. ( 29881543 )
2018
7
Prevalence of extended spectrum beta lactamase and plasmid mediated quinolone resistant genes in strains of Klebsiella pneumonia, Morganella morganii, Leclercia adecarboxylata and Citrobacter freundii isolated from poultry in South Western Nigeria. ( 29942700 )
2018
8
In Vitro/Vivo Activity of Potential MCR-1 Inhibitor in Combination With Colistin Againsts mcr-1-Positive Klebsiella pneumonia. ( 30065720 )
2018
9
Prospective investigation of carbapenem-resistant Klebsiella pneumonia transmission among the staff, environment, and patients in five major intensive care units, Beijing. ( 30529506 )
2018
10
Prostatic abscess of Klebsiella pneumonia complicating septic pulmonary emboli and meningitis: A case report and brief review. ( 28107857 )
2017
11
Implant-associated ESBL-Klebsiella pneumonia producing small colony variant bone and joint infection in a healthy 40-year-old man. ( 28167688 )
2017
12
Epithelial Myeloid-Differentiation Factor 88 Is Dispensable during Klebsiella Pneumonia. ( 28187270 )
2017
13
Dusuqing granules (DSQ) suppress inflammation in Klebsiella pneumonia rat via NF-κB/MAPK signaling. ( 28415997 )
2017
14
Diversity-oriented sustainable synthesis of antimicrobial spiropyrrolidine/thiapyrrolizidine oxindole derivatives: New ligands for a metallo-β-lactamase from Klebsiella pneumonia. ( 28487071 )
2017
15
Inhibition of nitric oxide production reverses diabetes-induced Kupffer cell activation and Klebsiella pneumonia liver translocation. ( 28493939 )
2017
16
Risk factors of mortality in bloodstream infections caused by Klebsiella pneumonia: A single-center retrospective study in China. ( 28858116 )
2017
17
Regulator of the mucoid phenotype A gene increases the virulent ability of extended-spectrum beta-lactamase-producing serotype non-K1/K2 Klebsiella pneumonia. ( 25442871 )
2016
18
Genotyping of Klebsiella Pneumonia Strains Isolated from Eldly Inpatients by Multiple-locus Variable-number Tandem-repeat Analysis. ( 27594157 )
2016
19
Klebsiella pneumonia liver abscess syndrome: Case presentation to a college student health clinic. ( 27628340 )
2016
20
DETECTION OF CTX-M GENE ANTIBIOTICS RESISTANCE IN KLEBSIELLA PNEUMONIA ISOLATES OF HOSPITALS IN ADJARA (GEORGIA). ( 27770529 )
2016
21
Molecular Identification of Extended-Spectrum β-lactamase and Integron Genes in Klebsiella Pneumonia. ( 27935927 )
2016
22
Piscidin is Highly Active against Carbapenem-Resistant Acinetobacter baumannii and NDM-1-Producing Klebsiella pneumonia in a Systemic Septicaemia Infection Mouse Model. ( 25874924 )
2015
23
Klebsiella pneumonia: An unusual cause of ophthalmia neonatorum in a healthy newborn. ( 26691043 )
2015
24
Persistence of a pKPN3-like CTX-M-15-encoding IncFIIK plasmid in a Klebsiella pneumonia ST17 host during two years of intestinal colonization. ( 25738592 )
2015
25
Molecular epidemiology of aminoglycosides resistance on Klebsiella pneumonia in a hospital in China. ( 25785141 )
2015
26
An outbreak of carbapenem-resistant OXA-48 - producing Klebsiella pneumonia associated to duodenoscopy. ( 25815166 )
2015
27
Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia Isolates. ( 26067824 )
2015
28
Syntrophic co-culture of Bacillus subtilis and Klebsiella pneumonia for degradation of kraft lignin discharged from rayon grade pulp industry. ( 26141897 )
2015
29
Comparative whole genome transcriptome and metabolome analyses of five Klebsiella pneumonia strains. ( 26296382 )
2015
30
Emergence of Carbapenemase Producing Klebsiella Pneumonia and Spread of KPC-2 and KPC-17 in Taiwan: A Nationwide Study from 2011 to 2013. ( 26384242 )
2015
31
Klebsiella pneumonia, a Microorganism that Approves the Non-linear Responses to Antibiotics and Window Theory after Exposure to Wi-Fi 2.4 GHz Electromagnetic Radiofrequency Radiation. ( 26396967 )
2015
32
Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand. ( 26407326 )
2015
33
Chronic Klebsiella pneumonia: a rare manifestation of Klebsiella pneumonia. ( 26543615 )
2015
34
Isolation and characterization of pyrene and benzo[a]pyrene-degrading Klebsiella pneumonia PL1 and its potential use in bioremediation. ( 24389667 )
2014
35
Immunoproteomic to analysis the pathogenicity factors in leukopenia caused by Klebsiella pneumonia bacteremia. ( 25330314 )
2014
36
Concurrent Endophthalmitis and Orbital Cellulitis From Metastatic Klebsiella pneumonia Liver Abscess. ( 25186218 )
2014
37
Low or high doses of cefquinome targeting low or high bacterial inocula cure Klebsiella pneumonia lung infections but differentially impact the levels of antibiotic resistance in fecal flora. ( 24395228 )
2014
38
First report of Klebsiella pneumonia carbapenemase-producing Pseudomonas aeruginosa isolated from burn patients in Iran: phenotypic and genotypic methods. ( 24653970 )
2014
39
String test of hypervirulent Klebsiella pneumonia. ( 24890554 )
2014
40
Comparative genomic analysis of Klebsiella pneumonia (LCT-KP214) and a mutant strain (LCT-KP289) obtained after spaceflight. ( 25015528 )
2014
41
In silico identification of potential virulence genes in 1,3-propanediol producer Klebsiella pneumonia. ( 25173613 )
2014
42
Characterization of resistance genes in 68 ESBL-producing Klebsiella pneumonia in Lebanon. ( 25453362 )
2014
43
Klebsiella pneumonia-induced prostate abscess: How to work it up? ( 25485013 )
2014
44
Perirenal haematoma with Klebsiella pneumonia pyelonephritis. ( 23291815 )
2013
45
Modulation of respiratory dendritic cells during Klebsiella pneumonia infection. ( 24044871 )
2013
46
Prevalence of plasmid-mediated AmpC I^-lactamases in Escherichia coli and Klebsiella pneumonia at tertiary care hospital of Islamabad, Pakistan. ( 24294496 )
2013
47
Increased susceptibility to Klebsiella pneumonia and mortality in GSNOR-deficient mice. ( 24239886 )
2013
48
Pharmacokinetics and ex-vivo pharmacodynamics of cefquinome against Klebsiella pneumonia in healthy dogs. ( 24372291 )
2013
49
A liver abscess deprived a healthy adult of eyesight: endogenous endophthalmitis associated with a pyogenic liver abscess caused by serotype K1 Klebsiella pneumonia. ( 23583997 )
2013
50
Implantable cardioverter defibrillator pocket infection caused by Klebsiella pneumonia. ( 23382757 )
2012
Sources

Variations for Klebsiella Pneumonia

About this section
Sources

Expression for Klebsiella Pneumonia

About this section
Search GEO for disease gene expression data for Klebsiella Pneumonia.
Sources

Pathways for Klebsiella Pneumonia

About this section

Pathways related to Klebsiella Pneumonia according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Selenium Micronutrient Network 1
Show member pathways
 10.96 MAT1A PLAT
Sources

GO Terms for Klebsiella Pneumonia

About this section
Sources

Sources for Klebsiella Pneumonia

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....